Matthildi Valianou

University of Tennessee Health Science Center — United States

Medicine · Health Sciences

8h-index859citations11works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(4), Protease and Inhibitor Mechanisms(3), Tuberous Sclerosis Complex Research(3), Cancer Cells and Metastasis(2), Cellular Mechanics and Interactions(2)

Publications11 total

Combination of Volasertib and Rapamycin Inhibits the Regrowth of TSC2-Deficient Tumors
2022Open Access
Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells
Scientific Reports·2019· 17 citedOpen Access
Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy
Cell Cycle·2015· 30 citedOpen Access
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens
The FASEB Journal·2012· 21 citedOpen Access
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells
BMC Cancer·2011· 291 citedOpen Access
Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins
BMC Cancer·2009· 109 citedOpen Access
Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner
Gynecologic Oncology·2008· 50 citedOpen Access
ID: 191 Fibroblast Activation Protein Confers Enhanced Motility in a Fibroblast Derived 3D Matrix System
Journal of Thrombosis and Haemostasis·2006
Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth
Molecular Cancer Therapeutics·2005· 127 cited
Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.
PubMed·2002· 214 cited
Heterogeneity of four β-thalassemia mutations in Greece
Hemoglobin·1999

Frequent Co-authors

Edna Cukierman(4), Jonathan D. Cheng(4), Aristotelis Astrinidis(4), Stefanie Mullins(3), Louis M. Weiner(3), Hyung‐Ok Lee(2), Daniel L. Johnson(2), Erik Y. Zhang(2), Jane Yu(2), John J. Bissler(2), Janusz Franco‐Barraza(1), Roland L. Dunbrack(1), André Rogatko(1), R. Katherine Alpaugh(1), Adrian A. Canutescu(1), Eileen K. Jaffe(1), Hyung-Ok Lee(1), Hao Wang(1), Jack H. Lai(1), William W. Bachovchin(1)